Taiwanese Pharmaceuticals & Biotech Potentially Undervalued Companies

Bora Pharmaceuticals

Market Cap: NT$65.6b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Chunghwa Chemical Synthesis & Biotech

Market Cap: NT$1.9b

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

PharmaEssentia

Market Cap: NT$167.7b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

HeXun Biosciences

Market Cap: NT$2.7b

Engages in the research and development of stem cell and treatments in Taiwan.

PharmaEngine

Market Cap: NT$10.2b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Maxigen Biotech

Market Cap: NT$3.4b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

Standard Chemical & Pharmaceutical

Market Cap: NT$11.1b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

Chi Sheng Pharma & Biotech

Market Cap: NT$1.8b

Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.

Anxo Pharmaceutical

Market Cap: NT$1.3b

A specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally.

Syngen BiotechLtd

Market Cap: NT$3.4b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

YungShin Global Holding

Market Cap: NT$14.7b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

TTY Biopharm

Market Cap: NT$19.6b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

TSH Biopharm

Market Cap: NT$2.0b

Develops and markets pharmaceutical products in Taiwan and Asia.

Cenra

Market Cap: NT$6.0b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Bioray Biotech

Market Cap: NT$701.2m

Engages in the research and development, manufacture, and sale of biological and health supplement products.

BioLASCO Taiwan

Market Cap: NT$794.0m

Provides bio-materials and surgical services in Taiwan and internationally.

3D Global Biotech

Market Cap: NT$3.5b

Develops medical materials for human body reconstruction in China.

Winston Medical Supply

Market Cap: NT$2.0b

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

Sinphar PharmaceuticalLtd

Market Cap: NT$5.7b

Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

Welgene BiotechLtd

Market Cap: NT$449.8m

Provides genetic testing services.

Nang Kuang Pharmaceutical

Market Cap: NT$3.9b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.